Shares of Evogene Ltd. (NASDAQ:EVGN) reached a new 52-week low on Wednesday . The company traded as low as $3.36 and last traded at $3.45, with a volume of 25900 shares. The stock had previously closed at $3.44.
A hedge fund recently raised its stake in Evogene stock. Vanguard Group Inc. boosted its stake in shares of Evogene Ltd. (NASDAQ:EVGN) by 4.2% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 436,225 shares of the biotechnology company’s stock after purchasing an additional 17,391 shares during the period. Vanguard Group Inc. owned approximately 1.70% of Evogene worth $2,443,000 at the end of the most recent quarter. Institutional investors and hedge funds own 30.94% of the company’s stock.
Evogene Company Profile
Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd.
What are top analysts saying about Evogene? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Evogene and related companies.